144 related articles for article (PubMed ID: 36934508)
41. Corneal Application of R9-SOCS1-KIR Peptide Alleviates Endotoxin-Induced Uveitis.
Ahmed CM; Patel AP; Ildefonso CJ; Johnson HM; Lewin AS
Transl Vis Sci Technol; 2021 Mar; 10(3):25. PubMed ID: 34003962
[TBL] [Abstract][Full Text] [Related]
42. New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries.
Doti N; Scognamiglio PL; Madonna S; Scarponi C; Ruvo M; Perretta G; Albanesi C; Marasco D
Biochem J; 2012 Apr; 443(1):231-40. PubMed ID: 22166051
[TBL] [Abstract][Full Text] [Related]
43. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
44. Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis.
He C; Yu CR; Sun L; Mahdi RM; Larkin J; Egwuagu CE
J Autoimmun; 2015 Aug; 62():31-8. PubMed ID: 26094775
[TBL] [Abstract][Full Text] [Related]
45. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
46. Suppressors of cytokine signalling: SOCS.
Larsen L; Röpke C
APMIS; 2002 Dec; 110(12):833-44. PubMed ID: 12645661
[TBL] [Abstract][Full Text] [Related]
47. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
[TBL] [Abstract][Full Text] [Related]
48. Expression and Purification of JAK1 and SOCS1 for Structural and Biochemical Studies.
Liau NPD; Babon JJ
Methods Mol Biol; 2018; 1725():267-280. PubMed ID: 29322424
[TBL] [Abstract][Full Text] [Related]
49. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
50. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
51. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
52. The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression.
Radtke S; Haan S; Jörissen A; Hermanns HM; Diefenbach S; Smyczek T; Schmitz-Vandeleur H; Heinrich PC; Behrmann I; Haan C
J Biol Chem; 2005 Jul; 280(27):25760-8. PubMed ID: 15894543
[TBL] [Abstract][Full Text] [Related]
53. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.
Ahmed CM; Dabelic R; Waiboci LW; Jager LD; Heron LL; Johnson HM
J Virol; 2009 Feb; 83(3):1402-15. PubMed ID: 19019946
[TBL] [Abstract][Full Text] [Related]
54. Understanding SOCS protein specificity.
Linossi EM; Calleja DJ; Nicholson SE
Growth Factors; 2018 Aug; 36(3-4):104-117. PubMed ID: 30318950
[TBL] [Abstract][Full Text] [Related]
55. SILAC proteomics implicates SOCS1 in modulating cellular macromolecular complexes and the ubiquitin conjugating enzyme UBE2D involved in MET receptor tyrosine kinase downregulation.
Santharam MA; Shukla A; Ihsan AU; Cloutier M; Levesque D; Ramanathan S; Boisvert FM; Ilangumaran S
Biochimie; 2021 Mar; 182():185-196. PubMed ID: 33493533
[TBL] [Abstract][Full Text] [Related]
56. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
[TBL] [Abstract][Full Text] [Related]
57. SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function.
Ahmed CM; Larkin J; Johnson HM
Front Immunol; 2015; 6():183. PubMed ID: 25954276
[TBL] [Abstract][Full Text] [Related]
58. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence.
Mallette FA; Calabrese V; Ilangumaran S; Ferbeyre G
Aging (Albany NY); 2010 Jul; 2(7):445-52. PubMed ID: 20622265
[TBL] [Abstract][Full Text] [Related]
59. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells.
Ushiki T; Huntington ND; Glaser SP; Kiu H; Georgiou A; Zhang JG; Metcalf D; Nicola NA; Roberts AW; Alexander WS
PLoS One; 2016; 11(9):e0162111. PubMed ID: 27583437
[TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory mechanisms of suppressors of cytokine signaling target ROS via NRF-2/thioredoxin induction and inflammasome activation in macrophages.
Kim GY; Jeong H; Yoon HY; Yoo HM; Lee JY; Park SH; Lee CE
BMB Rep; 2020 Dec; 53(12):640-645. PubMed ID: 33172542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
